Prediction of Atrial Fibrillation Using Polygenic Risk Score

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.

Also called NCT07641582

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07641582
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07641582. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-11-19 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prediction of Atrial Fibrillation Using Polygenic Risk Score
Acronym
PREGENCE
Condition
Atrial Fibrillation (AF)
Intervention (Device)
7-day continuous ECG (electrocardiogram) patch monitor
Intervention (Device)
Six-lead handheld electrocardiogram device
Intervention (Genetic)
SNP array genotyping
Lead sponsor
Seoul St. Mary's Hospital (class: other)

Record details

Record id
cardio:ct-nct07641582
Content hash
69375e709b0e211c2a30d8c8c9a146761e7ec5171179179201b0a93765c4700f